MNPR
Monopar Therapeutics Inc
78.00$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -30.7% | +1.7% | -40.5% | +39.9% | +386.3% | -5.6% | -14.1% | +0.4% | +53.3% | +84,274.9% | – | |
| – | – | – | – | – | +12,840.9% | -204.3% | – | – | +482.2% | -132.9% | – | – | |
| – | -66.7% | +200.0% | -33.3% | +0.0% | -100.0% | – | -75.0% | +100.0% | -100.0% | – | +0.0% | – | |
| – | – | -133.1% | -99.8% | – | -1,554.6% | -97.7% | – | -279.1% | +2,825.1% | -91.0% | – | – | |
| – | -35.2% | +101.9% | -6.9% | +165,240.0% | – | – | – | – | -100.0% | – | – | – | |
| – | +35.6% | +851.1% | -100.3% | +66.7% | – | -100.2% | +173.9% | – | -100.4% | -48.0% | +323,266.3% | – | |
| – | – | -69.1% | -411.7% | – | – | -115.3% | – | – | -174.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.